Many established medical therapies to treat myasthenia gravis remain in use, and newer options are available for patients who ...

The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia gravis ... an immune checkpoint inhibitor, after an 87-year-old patient ...

When patients are undergoing treatment for cancer, clinicians should be aware of the potential to develop myasthenia gravis from immune checkpoint inhibitors (ICI), new research stresses ...

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) ...

How Is Myasthenia Gravis Diagnosed? During a physical exam for myasthenia gravis, your health care provider may look for signs such as a droopy eyelid, difficulty holding your arms out at shoulder ...

The first of these was complement inhibitor eculizumab (Soliris ... a trend for greater change from baseline to week 26 in Myasthenia Gravis-Activities of Daily Living (MG-ADL) total score ...

Myasthenia gravis, or MG, is "a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue," says Hesterlee. It occurs "when a person’s immune system is essentially ...

Initial treatment for myasthenia gravis starts with cholinesterase inhibitors. This medication prevents the breakdown of acetylcholine, decreasing symptoms of muscle weakness. Mestinon ...

Generalized myasthenia gravis (gMG) affects most patients through ... Recently approved C5 complement inhibitors like eculizumab (Soliris), ravulizumab (Ultomiris), and zilucoplan (Zilbrysq ...